Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22748821 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo identical to BI 1356 5mg;   Drug: Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4 mg;   Drug: BI 1356;   Drug: Glimepiride

Indicates status has not been verified in more than two years